A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia
Open Access
- 1 March 2003
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 40 (3) , 163-168
- https://doi.org/10.1136/jmg.40.3.163
Abstract
Familial hypercholesterolaemia (FH) is a common autosomal codominant hereditary disease caused by defects in the LDL receptor (LDLR) gene, and one of the most common characteristics of affected subjects is premature coronary heart disease (CHD). In heterozygous FH patients, the clinical expression of FH is highly variable in terms of the severity of hypercholesterolaemia and the age of onset and severity of CHD. Identification of mutations in the ATP binding cassette transporter 1 (ABCA1) gene in patients with Tangier disease, who exhibit reduced HDL cholesterol and apolipoprotein A1 concentrations and premature coronary atherosclerosis, has led us to hypothesise that ABCA1 could play a key role in the onset of premature CHD in FH. In order to know if the presence of the R219K variant in the ABCA1 gene could be a protective factor for premature CHD in FH, we have determined the presence of this genetic variant by amplification by PCR and restriction analysis in a group of 374 FH subjects, with and without premature CHD. The K allele of the R219K variant was significantly more frequent in FH subjects without premature CHD (0.32, 95% CI 0.27 to 0.37) than in FH subjects with premature CHD (0.25, 95% CI 0.21 to 0.29) (pABCA1 could influence the development and progression of atherosclerosis in FH subjects. Moreover, the K allele of the R219K polymorphism seems to modify CHD risk without important modification of plasma HDL-C levels, and it appears to be more protective for smokers than non-smokers.Keywords
This publication has 32 references indexed in Scilit:
- ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levelsClinical Genetics, 2002
- Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemiaPublished by Oxford University Press (OUP) ,2001
- Tangier disease and ABCA1Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2000
- Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotesJournal of Clinical Investigation, 2000
- A Functional Polymorphism in the Promoter Region of the Microsomal Triglyceride Transfer Protein (MTP −493G/T) Influences Lipoprotein Phenotype in Familial HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Molecular Cloning of the Human ATP-Binding Cassette Transporter 1 (hABC1): Evidence for Sterol-Dependent Regulation in MacrophagesBiochemical and Biophysical Research Communications, 1999
- PlA1/A2 polymorphism of platelet glycoprotein IIIa and risk of acute coronary syndromes in heterozygous familial hypercholesterolemiaAtherosclerosis, 1999
- Isolated Low HDL Cholesterol As a Risk Factor for Coronary Heart Disease MortalityArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Cloning of Two Novel ABC Transporters Mapping on Human Chromosome 9Genomics, 1994
- High density lipoprotein cholesterol and mortality. The Framingham Heart Study.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988